DU 608
Formula : C26-H29-Cl-N2-O2.2Cl-H
CAS :
57779-29-0
DU 717
Formula : C12-H15-Cl-N4-O2-S
CAS :
59943-31-6
DU-1102
Formula : C34-H34-Cl-N3-O3.2C6-H8-O7
CAS :
324761-14-0
UNII-457LFY2K88
DU-1102
1|2-Ethanediamine| N1-(4'a|7'a-dihydro-6'|7'a-diphenylspiro(cyclohexane-1|3'-(7H)cyclopenta(1|2|4)trioxin)-4-yl)-N2-(7-chloro-4-quinolinyl)-| 2-hydroxy-1|2|3-propanetricarboxylate (1:2)
1|2-Ethanediamine| N-(7-chloro-4-quinolinyl)-N'-(4'a|7'a-dihydro-6'|7'a-diphenylspiro(cyclohexane-1|3'-(7H)cyclopenta(1|2|4)trioxin)-4-yl)-| 2-hydroxy-1|2|3-propanetricarboxylate (1:2)
ODC-218
A trioxaquine.
DU-124183
Formula : C21-H20-N4
CAS :
132206-99-6
An A3 adenosine receptor agonist.
DU-127090
Formula :
CAS :
362524-71-8
Is a mixed dopamine antagonist/serotonin agonist in development by Solvay and H Lundbeck as a potential treatment for psychosis and schizophrenia, .
DU-1302
Formula : C27-H36-Cl-N3-O3.2C6-H8-O7
CAS :
367279-40-1
UNII-JGB4GN1J78
DU-1302
1|2-Ethanediamine| N1-(7-chloro-4-quinolinyl)-N2-(4a|7|8|8a-tetrahydro-8a-methyl-6-(1-methylethyl)spiro(1|2|4-benzotrioxin-3|1'-cyclohexan)-4'-yl)-| 2-hydroxy-1|2|3-propanetricarboxylate (1:2)
1|2-Ethanediamine| N-(7-chloro-4-quinolinyl)-N'-(4a|7|8|8a-tetrahydro-8a-methyl-6-(1-methylethyl)spiro(1|2|4-benzotrioxin-3|1'-cyclohexan)-4'-yl)-| 2-hydroxy-1|2|3-propanetricarboxylate (1:2)
DU-1302 free base
Formula : C27-H36-Cl-N3-O3
CAS :
367265-64-3
UNII-8761E54RFF
DU-1302 free base
1|2-Ethanediamine| N1-(7-chloro-4-quinolinyl)-N2-(4a|7|8|8a-tetrahydro-8a-methyl-6-(1-methylethyl)spiro(1|2|4-benzotrioxin-3|1'-cyclohexan)-4'-yl)-
1|2-Ethanediamine| N-(7-chloro-4-quinolinyl)-N'-(4a|7|8|8a-tetrahydro-8a-methyl-6-(1-methylethyl)spiro(1|2|4-benzotrioxin-3|1'-cyclohexan)-4'-yl)-
DU-6712
Formula : C18-H19-Cl-N4-O3
CAS :
173589-74-7
Dual cement
Formula :
CAS :
131257-49-3
Cpd is biocompatible.